During the past decade, Hospital de Clinicas da Universidade Federal do Parana conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Clinicas da Universidade Federal do Parana" #1 sponsor was "Astellas Pharma Inc" with 3 trials, followed by "Eisai Inc." with 2 trials sponsored, "Eurofarma Laboratorios S.A." with 2 trials sponsored, "Hospital de Clinicas de Porto Alegre" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Clinicas da Universidade Federal do Parana" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Brainomix Limited" with 1 trials as a collaborator, "Federal University of São Paulo" with 1 trials as a collaborator and "Federal University of Uberlandia" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Clinicas da Universidade Federal do Parana" are "Aspergillosis" (2 trials), "COVID-19" (2 trials), "Candidemia" (2 trials), "Depressive Disorder, Major" (2 trials) and "Aneurysmal Subarachnoid Hemorrhage" (1 trials). Many other conditions were trialed in "Hospital de Clinicas da Universidade Federal do Parana" in a lesser frequency.

Most popular intervention types in "Hospital de Clinicas da Universidade Federal do Parana" are "Drug" (21 trials), "Other" (3 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Aticaprant" (2 trials), "Isavuconazole" (2 trials), "Thrombectomy" (2 trials) and "Voriconazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Clinicas da Universidade Federal do Parana" are 27 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Clinicas da Universidade Federal do Parana". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Hospital de Clinicas da Universidade Federal do Parana, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Clinicas da Universidade Federal do Parana, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".